Nickel-induced transformation shifts the balance between HIF-1 and p53 transcription factors

被引:121
作者
Salnikow, K [1 ]
An, WG
Melillo, G
Blagosklonny, MV
Costa, M
机构
[1] NYU Med Ctr, Nelson Inst Environm Med, New York, NY 10016 USA
[2] NYU Med Ctr, Kaplan Comprehens Canc Ctr, New York, NY 10016 USA
[3] NCI, Med Branch, NIH, Bethesda, MD 20892 USA
关键词
D O I
10.1093/carcin/20.9.1819
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Nickel (Ni) compounds are potent carcinogens and can induce malignant transformation of rodent and human cells. In an attempt to unravel the molecular mechanisms of Ni-induced transformation we investigated transcriptional activity of hypoxia-inducible factor (HIF-1) and p53 tumor suppressor protein in Ni-transformed cells, We demonstrated that the activity of HIF-1-responsive promoters was increased in Ni-transformed rodent cells resulting in the increased ratio between HIF-1- and p53-stimulated transcription. To further elucidate the roles of HIF-1 and p53 in Ni-induced transformation we used human osteosarcoma (HOS) cells and a Ni-transformed derivative, SA-8 cells. Since non-functional p53 was expressed in both HOS and SA-8 cells, acute Ni treatment induced HIF-1 alpha protein and HIF-1-dependent transcription without affecting p53. In MCF-7 and A549, human cancer cells with the wild-type p53, both functional p53 and HIF-1 alpha proteins accumulated following exposure to Ni, The induction of HIF-1 alpha and wild-type p53 by Ni was detected after 6 h and was most pronounced by 24 h, These results suggest that acute Ni treatment causes accumulation of HIF-1 alpha protein and simultaneous accumulation of wild-type, but not mutant, p53. We suggest that the induction of hypoxia-like conditions in Ni-treated cells with subsequent selection for increased HIF-1-dependent transcription is involved in Ni-induced carcinogenesis.
引用
收藏
页码:1819 / 1823
页数:5
相关论文
共 47 条
[1]   Stabilization of wild-type p53 by hypoxia-inducible factor 1α [J].
An, WG ;
Kanekal, M ;
Simon, MC ;
Maltepe, E ;
Blagosklonny, MV ;
Neckers, LM .
NATURE, 1998, 392 (6674) :405-408
[2]   Inhibitors of transcription, proteasome inhibitors, and DNA-damaging drugs differentially affect feedback of p53 degradation [J].
An, WG ;
Chuman, Y ;
Fojo, T ;
Blagosklonny, MV .
EXPERIMENTAL CELL RESEARCH, 1998, 244 (01) :54-60
[3]  
BIEDERMANN KA, 1987, CANCER RES, V47, P3815
[4]   p53 inhibits hypoxia-inducible factor-stimulated transcription [J].
Blagosklonny, MV ;
An, WG ;
Romanova, LY ;
Trepel, J ;
Fojo, T ;
Neckers, L .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (20) :11995-11998
[5]  
Blagosklonny MV, 1996, INT J CANCER, V67, P386, DOI 10.1002/(SICI)1097-0215(19960729)67:3<386::AID-IJC13>3.0.CO
[6]  
2-6
[7]   Loss of function and p53 protein stabilization [J].
Blagosklonny, MV .
ONCOGENE, 1997, 15 (16) :1889-1893
[8]   Role of HIF-1α or in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis [J].
Carmeliet, P ;
Dor, Y ;
Herbert, JM ;
Fukumura, D ;
Brusselmans, K ;
Dewerchin, M ;
Neeman, M ;
Bono, F ;
Abramovitch, R ;
Maxwell, P ;
Koch, CJ ;
Ratcliffe, P ;
Moons, L ;
Jain, RK ;
Collen, D ;
Keshet, E .
NATURE, 1998, 394 (6692) :485-490
[9]  
CONWAY K, 1989, CANCER RES, V49, P6032
[10]  
COSTA M, 1991, ANNU REV PHARMACOL, V31, P321